C. Neville et al., Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada, J RHEUMATOL, 28(7), 2001, pp. 1505-1510
Objective. The Rheumatoid Arthritis Quality of Life questionnaire (RAQoL) w
as developed simultaneously in the UK and the Netherlands to measure qualit
y of life in patients with RA. We adapted and validated the RAQoL for the E
nglish-Canadian and French-Canadian languages and culture.
Methods, The UK RAQoL was translated into French-Canadian by a bilingual tr
anslation panel, Separate lay panels were then used to ensure that this and
the English-Canadian instruments were appropriate for use with Canadian pa
tients. Interviews were conducted with 15 French-Canadian and 15 English-Ca
nadian patients with RA to determine the content validity. Reliability and
construct validity were established by means of test-retest mail surveys co
nducted with 92 French-Canadian and 87 English-Canadian RA patients. The su
rvey consisted of the adapted RAQoL, the Health Assessment Questionnaire (H
AQ), and a demographic questionnaire,
Results. The RAQoL was successfully adapted for both the French and English
-Canadian cultures. Field testing showed both Versions to be well received
by respondents. Of the French-Canadian patients included in the postal surv
ey, 52 responded at Time 1 and 50 at Time 2, For the English-Canadian sampl
e, 54 responded at both time points. Missing data rates for the RAQoL were
low and floor and ceiling effects were minimal, Test-retest reliability was
good for both versions: 0.87 for the French-Canadian and 0.95 for the Engl
ish-Canadian, Alpha coefficients (0.92 for the French-Canadian. 0.93 for th
e English-Canadian) showed the items to be adequately interrelated and scor
es on the measure showed moderate to high correlations with the HAQ, confir
ming construct validity. Both versions of the RAQoL were also able to disti
nguish patient groups that differed according to perceived health status an
d perceived severity of RA, In addition, the French-Canadian version was ab
le to distinguish patients who rated today as bad or very bad from those wh
o rated today as good or very good.
Conclusion. The new versions of the RAQoL were well received by both French
and English speaking Canadians. The psychometric quality of the adapted qu
estionnaires means they are suitable for inclusion in clinical trials invol
ving patients with RA.